T.Perez-TilveD.WardB.et al
While its essential to continue with proven, disease-modifying treatments to effectively manage the autoimmune disorder, GLP-1 agonists can offer added support, especially for addressing residual inflammation or metabolic issues

and awake tracheal extubation." 2.5 Comparison with Other Guidelines: 2.5.1 ASA Guidelines: A multisociety consensus for the perioperative management of patients taking GLP1 RAs was developed by representatives from: The American Society of Anesthesiologists The American Gastroenterological Association The American Society for Metabolic and Bariatric Surgery The International Society of Perioperative Care of Patients with Obesity The Society of American Gastrointestinal and Endoscopic Surgeons Recommendation 1 [2] : Consider variables that increase the risk of delayed gastric emptying and aspiration with the periprocedural use of GLP-1RA: - The escalation phase of the medication- Higher doses- Weekly dosing- The presence of gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, and constipation) suggestive of delayed gastric emptying- Other medical conditions that may delay gastric emptying

The recommended dosage for Dihexa ranges between 5 mg to 20 mg daily, which should be adjusted based on individual response, body weight, and specific cognitive enhancement goals
R -lipoic acid occurs naturally in food (see Food sources)